Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1979 1
1981 1
1982 3
1983 4
1984 2
1985 7
1986 2
1987 1
1988 7
1989 5
1990 8
1991 11
1992 6
1993 9
1994 12
1995 16
1996 13
1997 11
1998 15
1999 29
2000 28
2001 27
2002 24
2003 29
2004 34
2005 26
2006 30
2007 36
2008 58
2009 32
2010 47
2011 64
2012 61
2013 69
2014 72
2015 71
2016 64
2017 77
2018 69
2019 63
2020 75
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

1,133 results
Results by year
Filters applied: . Clear all
Page 1
IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis.
Tanaka A. Tanaka A. Gut Liver. 2019 May 15;13(3):300-307. doi: 10.5009/gnl18085. Gut Liver. 2019. PMID: 30205418 Free PMC article. Review.
Sclerosing cholangitis (SC) is defined as a condition with progressive stenosis and destruction of the bile ducts due to diffuse inflammation and fibrosis and currently includes three categories: primary sclerosing cholangitis (PSC), secondary
Sclerosing cholangitis (SC) is defined as a condition with progressive stenosis and destruction of the bile ducts due to diffu
Primary sclerosing cholangitis.
Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M. Dyson JK, et al. Lancet. 2018 Jun 23;391(10139):2547-2559. doi: 10.1016/S0140-6736(18)30300-3. Epub 2018 Feb 13. Lancet. 2018. PMID: 29452711 Review.
Primary sclerosing cholangitis is a rare, chronic cholestatic liver disease characterised by intrahepatic or extrahepatic stricturing, or both, with bile duct fibrosis. ...Approximately 70% of patients have concurrent inflammatory bowel disease and patients r
Primary sclerosing cholangitis is a rare, chronic cholestatic liver disease characterised by intrahepatic or extrahepat
Primary Sclerosing Cholangitis: A Concise Review of Diagnosis and Management.
Fricker ZP, Lichtenstein DR. Fricker ZP, et al. Dig Dis Sci. 2019 Mar;64(3):632-642. doi: 10.1007/s10620-019-05484-y. Epub 2019 Feb 6. Dig Dis Sci. 2019. PMID: 30725292 Review.
Primary sclerosing cholangitis is a rare, chronic cholestatic liver disease characterized by progressive idiopathic stricturing of the biliary system, typically leading to cirrhosis, end-stage liver disease, and colonic or hepatobiliary malignancy. ...There i
Primary sclerosing cholangitis is a rare, chronic cholestatic liver disease characterized by progressive idiopathic str
Primary sclerosing cholangitis - a comprehensive review.
Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Karlsen TH, et al. J Hepatol. 2017 Dec;67(6):1298-1323. doi: 10.1016/j.jhep.2017.07.022. Epub 2017 Aug 10. J Hepatol. 2017. PMID: 28802875 Free article. Review.
Primary sclerosing cholangitis (PSC) is a rare disorder characterised by multi-focal bile duct strictures and progressive liver disease. Inflammatory bowel disease is usually present and there is a high risk of cholangiocarcinoma and colorectal cancer.
Primary sclerosing cholangitis (PSC) is a rare disorder characterised by multi-focal bile duct strictures and progressi
Primary sclerosing cholangitis and inflammatory bowel disease: Intestine-liver interrelation.
Núñez F P, Quera P R, Gomollón F. Núñez F P, et al. Gastroenterol Hepatol. 2019 May;42(5):316-325. doi: 10.1016/j.gastrohep.2019.02.004. Epub 2019 Apr 1. Gastroenterol Hepatol. 2019. PMID: 30948141 Review. English, Spanish.
The association between inflammatory bowel disease (IBD) and primary sclerosing cholangitis should be considered a distinct clinical entity. ...Furthermore, there is an increased risk of colorectal cancer and cholangiocarcinoma. The aim of this review …
The association between inflammatory bowel disease (IBD) and primary sclerosing cholangitis should be considered a dist …
Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.
Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD. Eaton JE, et al. Gastroenterology. 2013 Sep;145(3):521-36. doi: 10.1053/j.gastro.2013.06.052. Epub 2013 Jul 1. Gastroenterology. 2013. PMID: 23827861 Free PMC article. Review.
Primary sclerosing cholangitis (PSC), first described in the mid-1850s, is a complex liver disease that is heterogeneous in its presentation. ...
Primary sclerosing cholangitis (PSC), first described in the mid-1850s, is a complex liver disease that is heterogeneou
Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.
Palmela C, Peerani F, Castaneda D, Torres J, Itzkowitz SH. Palmela C, et al. Gut Liver. 2018 Jan 15;12(1):17-29. doi: 10.5009/gnl16510. Gut Liver. 2018. PMID: 28376583 Free PMC article. Review.
Primary sclerosing cholangitis (PSC) is a chronic, progressive cholestatic disease that is associated with inflammatory bowel disease (IBD) in approximately 70% of cases. ...There is conflicting evidence regarding the course of IBD in PSC-IBD patients who rec
Primary sclerosing cholangitis (PSC) is a chronic, progressive cholestatic disease that is associated with inflammatory
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.
Arbelaiz A, Azkargorta M, Krawczyk M, Santos-Laso A, Lapitz A, Perugorria MJ, Erice O, Gonzalez E, Jimenez-Agüero R, Lacasta A, Ibarra C, Sanchez-Campos A, Jimeno JP, Lammert F, Milkiewicz P, Marzioni M, Macias RIR, Marin JJG, Patel T, Gores GJ, Martinez I, Elortza F, Falcon-Perez JM, Bujanda L, Banales JM. Arbelaiz A, et al. Hepatology. 2017 Oct;66(4):1125-1143. doi: 10.1002/hep.29291. Epub 2017 Aug 26. Hepatology. 2017. PMID: 28555885
Cholangiocarcinoma (CCA) includes a heterogeneous group of biliary cancers with poor prognosis. Several conditions, such as primary sclerosing cholangitis (PSC), are risk factors. Noninvasive differential diagnosis between intrahepatic CCA and hepatoce
Cholangiocarcinoma (CCA) includes a heterogeneous group of biliary cancers with poor prognosis. Several conditions, such as primar
Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
Song J, Li Y, Bowlus CL, Yang G, Leung PSC, Gershwin ME. Song J, et al. Clin Rev Allergy Immunol. 2020 Feb;58(1):134-149. doi: 10.1007/s12016-019-08764-7. Clin Rev Allergy Immunol. 2020. PMID: 31463807 Review.
Cholangiocarcinoma (CCA) is the most common malignancy in patients with primary sclerosing cholangitis (PSC) and carries a high rate of mortality. ...
Cholangiocarcinoma (CCA) is the most common malignancy in patients with primary sclerosing cholangitis (PSC) and
Cholangiocarcinoma: Current Knowledge and New Developments.
Blechacz B. Blechacz B. Gut Liver. 2017 Jan 15;11(1):13-26. doi: 10.5009/gnl15568. Gut Liver. 2017. PMID: 27928095 Free PMC article. Review.
Cholangiocarcinoma (CCA) is the second most common primary malignancy. Although it is more common in Asia, its incidence in Europe and North America has significantly increased in recent decades. ...
Cholangiocarcinoma (CCA) is the second most common primary malignancy. Although it is more common in Asia, its incidence in Eu
1,133 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page